tm
Seeing Is Believing
tm
Seeing Is Believing
DSGN is currently covered by 4 analysts with an average price target of $7.95. This is a potential upside of $4.62 (138.74%) from yesterday's end of day stock price of $3.33.
Design Therapeutics's activity chart (see below) currently has 17 price targets and 22 ratings on display. The stock rating distribution of DSGN is 36.36% BUY and 63.64% HOLD.
Analysts average stock forecasts to be materialized ratio is 25% with an average time for these price targets to be met of 225.33 days.
Highest price target for DSGN is $8, Lowest price target is $2, average price target is $7.67.
Most recent stock forecast was given by YASMEEN RAHIMI from PIPER SANDLER on 07-May-2024. First documented stock forecast 20-Apr-2021.
Currently out of the existing stock ratings of DSGN, 4 are a BUY (36.36%), 7 are a HOLD (63.64%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$12
$7.35 (158.06%)
1 years 2 days ago
(07-May-2024)
0/4 (0%)
$7.31 (155.86%)
Hold
$5
$0.35 (7.53%)
$6
1 years 5 months 25 days ago
(14-Nov-2023)
3/6 (50%)
$2.71 (118.34%)
247
Hold
$6
$1.35 (29.03%)
$22
1 years 8 months 24 days ago
(15-Aug-2023)
1/4 (25%)
$3.83 (176.50%)
429
What is DSGN (Design Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on DSGN (Design Therapeutics) with a proven track record?
Which analyst has the current lower performing score on DSGN (Design Therapeutics) with a proven track record?
Which analyst has the most public recommendations on DSGN (Design Therapeutics)?
Which analyst is the currently most bullish on DSGN (Design Therapeutics)?
Which analyst is the currently most reserved on DSGN (Design Therapeutics)?
